by DAVID.KIEWLICH | Aug 21, 2026 | Biotech
Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...
by DAVID.KIEWLICH | Aug 13, 2026 | Biotech
Biotech is the cutting edge of human advancement. Gene therapies are curing rare diseases. Cell-based immunotherapies are redefining oncology. Carbon-capturing biology and engineered materials are shaping climate change. The research has never been more exciting. Yet...
by DAVID.KIEWLICH | Jul 24, 2026 | Cell Therapy
The age of cell and gene therapy is here. The FDA has already approved more than 30 cell and gene therapies since 2017, and the global AAV manufacturing market is continuing to expand. Science, however, has outpaced the infrastructure. Before startups run into a...
by DAVID.KIEWLICH | Jul 17, 2026 | Biotech
Got the passion and the brilliant idea? Do you know that the odds of turning your great scientific idea into a market-ready business are pretty slim? That’s because there’s simply no good access to lab space in the biotech space. For far too long, many of our best...
by DAVID.KIEWLICH | Jul 16, 2026 | Bio-Innovators
It often feels like the journey from a scientific discovery to a real world, impactful innovation involves a multitude of hurdles and bottlenecks. The bio-innovators who are so often driven by curiosity and discovery to change the world, can become frustrated with the...